New search | Conferencedetail
Print view

SMi's 5th Annual Biosimilars USA Conference

evvnt Platform / evvnt
Conference themes
This fifth annual event will gather a global audience of biosimilar experts and industry-thought leaders to discuss biosimilar manufacturing and commercialization considerations specific to the U.S.
Fresh from the press: On March 7th, 2018, the U.S.-FDA's Commissioner, Scott Gottlieb, MD, announced that Biosimilar medicines are now a top priority for the FDA.
Professional congress organizer (PCO)
SMi Group

Speakers: Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals USA, Christina Yunis, Global Biosimilars Market Development Lead, Pfizer Essential Health, Nigel Rulewski and more

Enquiries and Registration:

Tickets: Tickets:
Ms. Simi Sapal
Internal Medicine
Congress fees
USD 499,00
(Conference And 2 Workshops: USD 2997.0, Conference And 1 Workshop: USD 2498.0, Conference only : USD 1999.0, 2 Workshops only : USD 998.0, 1 Workshop only: USD 499.0, Promotional Literature Distribution : USD 1198.8)
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

AMREF - African Medical and Research FoundationÖsterreichische Akademie der ÄrzteÖsterreichisches Rotes KreuzCharité International AcademyAGEM - Arbeitsgemeinschaft Ethnomedizin e. V.Österreichische Gesellschaft für Public HealthHilfswerk AustriaFFG - 7. EU-Rahmenprogramm


Give us your professional opinion

Start survey

Start survey